New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 28, 2014
13:48 EDTSTJSt. Jude Medical expects to acquire rest of CardioMEMS in Q2
St. Jude Medical and CardioMEMS confirmed FDA approval of the CardioMEMS HF System. The CardioMEMS HF System is the first and only FDA-approved heart failure monitoring device that has been proven to significantly reduce HF hospital admissions when used by physicians to manage heart failure. In September 2010, St. Jude Medical invested $60M for 19% ownership of CardioMEMS, with an exclusive option to purchase the remaining 81% of the company for $375M. St. Jude Medical now intends to immediately exercise its exclusive option to acquire CardioMEMS, and expects to complete the acquisition in Q2.
News For STJ From The Last 14 Days
Check below for free stories on STJ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 2, 2014
09:57 EDTSTJSt. Jude Medical announces primary outcome two-year data from FAME 2 trial
Subscribe for More Information
September 1, 2014
15:59 EDTSTJSt. Jude Medical announces new Fractional Flow Reserve trial
Subscribe for More Information
August 31, 2014
13:53 EDTSTJSt. Jude Medical Quartet quadripolar lead performed better than bipolar leads
Subscribe for More Information
August 28, 2014
17:42 EDTSTJJ&J begins sales process for its medical device unit Cordis, WSJ says
Subscribe for More Information
August 26, 2014
16:29 EDTSTJSt. Jude Medical resolves FDA warning letter for Plano facility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use